C.F.R. homeSearch C.F.R.
C.F.R.Title 45Subchapter A—General AdministrationPart 46—Protection of Human SubjectsSubpart A—Basic Hhs Policy for Protection of Human Research Subjects

45 C.F.R. § 46.102 (2026)

Definitions for purposes of this policy

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1976–2025 18citing cases
At a glance

Courts have cited this section in 18 opinions since 1976, 1 of them in the last five years.

(a) Certification means the official notification by the institution to the supporting Federal department or agency component, in accordance with the requirements of this policy, that a research project or activity involving human subjects has been reviewed and approved by an IRB in accordance with an approved assurance.

(b) Clinical trial means a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.

(c) Department or agency head means the head of any Federal department or agency, for example, the Secretary of HHS, and any other officer or employee of any Federal department or agency to whom the authority provided by these regulations to the department or agency head has been delegated.

(d) Federal department or agency refers to a federal department or agency (the department or agency itself rather than its bureaus, offices or divisions) that takes appropriate administrative action to make this policy applicable to the research involving human subjects it conducts, supports, or otherwise regulates (e.g., the U.S. Department of Health and Human Services, the U.S. Department of Defense, or the Central Intelligence Agency).

(e)(1) Human subject means a living individual about whom an investigator (whether professional or student) conducting research:

(i) Obtains information or biospecimens through intervention or interaction with the individual, and uses, studies, or analyzes the information or biospecimens; or

(ii) Obtains, uses, studies, analyzes, or generates identifiable private information or identifiable biospecimens.

(2) Intervention includes both physical procedures by which information or biospecimens are gathered (e.g., venipuncture) and manipulations of the subject or the subject's environment that are performed for research purposes.

(3) Interaction includes communication or interpersonal contact between investigator and subject.

(4) Private information includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place, and information that has been provided for specific purposes by an individual and that the individual can reasonably expect will not be made public (e.g., a medical record).

(5) Identifiable private information is private information for which the identity of the subject is or may readily be ascertained by the investigator or associated with the information.

(6) An identifiable biospecimen is a biospecimen for which the identity of the subject is or may readily be ascertained by the investigator or associated with the biospecimen.

(7) Federal departments or agencies implementing this policy shall:

(i) Upon consultation with appropriate experts (including experts in data matching and re-identification), reexamine the meaning of “identifiable private information,” as defined in paragraph (e)(5) of this section, and “identifiable biospecimen,” as defined in paragraph (e)(6) of this section. This reexamination shall take place within 1 year and regularly thereafter (at least every 4 years). This process will be conducted by collaboration among the Federal departments and agencies implementing this policy. If appropriate and permitted by law, such Federal departments and agencies may alter the interpretation of these terms, including through the use of guidance.

(ii) Upon consultation with appropriate experts, assess whether there are analytic technologies or techniques that should be considered by investigators to generate “identifiable private information,” as defined in paragraph (e)(5) of this section, or an “identifiable biospecimen,” as defined in paragraph (e)(6) of this section. This assessment shall take place within 1 year and regularly thereafter (at least every 4 years). This process will be conducted by collaboration among the Federal departments and agencies implementing this policy. Any such technologies or techniques will be included on a list of technologies or techniques that produce identifiable private information or identifiable biospecimens. This list will be published in the Federal Register after notice and an opportunity for public comment. The Secretary, HHS, shall maintain the list on a publicly accessible Web site.

(f) Institution means any public or private entity, or department or agency (including federal, state, and other agencies).

(g) IRB means an institutional review board established in accord with and for the purposes expressed in this policy.

(h) IRB approval means the determination of the IRB that the research has been reviewed and may be conducted at an institution within the constraints set forth by the IRB and by other institutional and federal requirements.

(i) Legally authorized representative means an individual or judicial or other body authorized under applicable law to consent on behalf of a prospective subject to the subject's participation in the procedure(s) involved in the research. If there is no applicable law addressing this issue, legally authorized representative means an individual recognized by institutional policy as acceptable for providing consent in the nonresearch context on behalf of the prospective subject to the subject's participation in the procedure(s) involved in the research.

(j) Minimal risk means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.

(k) Public health authority means an agency or authority of the United States, a state, a territory, a political subdivision of a state or territory, an Indian tribe, or a foreign government, or a person or entity acting under a grant of authority from or contract with such public agency, including the employees or agents of such public agency or its contractors or persons or entities to whom it has granted authority, that is responsible for public health matters as part of its official mandate.

(l) Research means a systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge. Activities that meet this definition constitute research for purposes of this policy, whether or not they are conducted or supported under a program that is considered research for other purposes. For example, some demonstration and service programs may include research activities. For purposes of this part, the following activities are deemed not to be research:

(1) Scholarly and journalistic activities (e.g., oral history, journalism, biography, literary criticism, legal research, and historical scholarship), including the collection and use of information, that focus directly on the specific individuals about whom the information is collected.

(2) Public health surveillance activities, including the collection and testing of information or biospecimens, conducted, supported, requested, ordered, required, or authorized by a public health authority. Such activities are limited to those necessary to allow a public health authority to identify, monitor, assess, or investigate potential public health signals, onsets of disease outbreaks, or conditions of public health importance (including trends, signals, risk factors, patterns in diseases, or increases in injuries from using consumer products). Such activities include those associated with providing timely situational awareness and priority setting during the course of an event or crisis that threatens public health (including natural or man-made disasters).

(3) Collection and analysis of information, biospecimens, or records by or for a criminal justice agency for activities authorized by law or court order solely for criminal justice or criminal investigative purposes.

(4) Authorized operational activities (as determined by each agency) in support of intelligence, homeland security, defense, or other national security missions.

(m) Written, or in writing, for purposes of this part, refers to writing on a tangible medium (e.g., paper) or in an electronic format.

The 18 cases that cite 45 C.F.R. § 46.102 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENSherley v. Sebelius, 644 F.3d 388 (D.C. Cir. 2011).
cites § 46.102 6×cited by 464 cases
Where it cites § 46.102
“The plaintiffs refer us to 45 C.F.R. § 46.102 (d), supra at 394 n. *; see also, e.”
The case’s holding
A likelihood of success on the merits is an independent requirement for a preliminary injunction that may be balanced against other factors in a preliminary injunction analysis.
Later courts cite it for
“read winter at least to suggest if not to hold 'that a likelihood of success is an independent, free-standing requirement for a preliminary injunction.” · 122 citing courts
2
cites § 46.102 1×cited by 68 cases
Where it cites § 46.102
“* (quoting 45 C.F.R. § 46.102 (d) ). Notwithstanding this temporally broad definition, the majority declared that the "definition of research is flexible enough to describe either a discrete project or an extended process.”
The case’s holding
A court possesses broad discretion to grant or deny an agency's motion to remand, generally granting it if the agency intends to take further action on the original decision.
Later courts cite it for
“broad discretion to grant or deny an agency's motion to remand.” · 11 citing courts
3
GREENKennedy Krieger Inst., Inc. v. Partlow, 191 A.3d 425 (Md. 2018).
cites § 46.102 1×cited by 22 cases
Where it cites § 46.102
“At oral argument, Ashley's counsel noted that, in its amicus brief, Johns Hopkins cited 45 C.F.R. § 46.102 (f), a regulation in Part 46, which sets forth the Department of Health and Human Services's policy for protection of human research subjects.”
Later courts cite it for
“because 'there can be no negligence where there is no duty that is due,' an analysis as to negligence usually begins 'with the question of whether a legally cognizable duty exists.” · 4 citing courts
4
GREENCrane v. Mathews, 417 F. Supp. 532 (N.D. Ga. 1976).
cites § 46.102 3×cited by 15 cases
Where it cites § 46.102
“45 C.F.R. §§ 46.102 (a), (b), 46.111(a). The review by the IRB must determine at the outset whether human subjects will be placed at risk by the proposed project.”
Later courts cite it for
“set forth in considerable detail the ... objectives which the project was designed to achieve.” · 2 citing courts
5
GREENVodopest v. MacGregor, 913 P.2d 779 (Wash. 1996).
cites § 46.102 2×cited by 28 cases
Where it cites § 46.102
“1988); see Department of Health and Human Services Rules and Regulations, 45 C.F.R. § 46.102 (d) (1994) (research means a systematic investigation designed to develop or contribute to generalizable knowledge).”
The case’s holding
A preinjury agreement releasing a researcher from liability for negligence occurring during medical research is unenforceable as a violation of public policy.
Later courts cite it for
“falls greatly below the standard established by law for the protection of others.” · 1 citing court
6
GREENSherley v. Sebelius, 704 F. Supp. 2d 63 (D.D.C. 2010).
cites § 46.102 2×cited by 12 cases
Where it cites § 46.102
“” 45 C.F.R. § 46.102 (d); see also Random House Diet, (listing the first definition of research as “diligent and systematic inquiry or investigation into a subject in order to discover or revise facts, theories, applications, etc.”
Later courts cite it for
“research in which a human embryo or embryos are destroyed.” · 2 citing courts
7
GREENAncheff v. Hartford Hosp., 799 A.2d 1067 (Conn. 2002).
cites § 46.102 2×cited by 12 cases
Where it cites § 46.102
“”45 C.F.R. § 46.102 (d); see footnote 15 of this opinion for the full text of this definition.”
Later courts cite it for
“unfair prejudice is that which unduly arouse s the jury's emotions of prejudice, hostility or sympathy ... or tends to have some adverse effect upon the party against whom the evidence is offered beyond tending to prove the fact or issue that justified its admission into evidence.” · 3 citing courts
8
GREENMargaret S. v. Edwards, 488 F. Supp. 181 (E.D. La. 1980).
cites § 46.102 1×cited by 65 cases
Where it cites § 46.102
“Rational adults, capable of informed consent, may wish to participate in experiments or to engage in occupations harmful to their health for many reasons: money, fame, idealism, or, in the case of prisoners, the hope of freedom.”
The case’s holding
A state requirement that post-first trimester abortions be performed in hospitals is unconstitutional if it lacks a rational relationship to maternal health and restricts access unnecessarily.
Later courts cite it for
“the state can choose to be prepared for those rare instances when there is a live birth.” · 2 citing courts
9
GREENSherley v. Sebelius, 776 F. Supp. 2d 1 (D.D.C. 2011).
cites § 46.102 2×cited by 7 cases
Where it cites § 46.102
“(quoting 45 C.F.R. § 46.102 (d)). Rejecting defendants’ argument that “research” meant “a piece of research,” this Court found that the Dickey-Wicker Amendment’s prohibition “encompasses all ‘research in which’ an embryo is destroyed, not just the ‘piece of research’ in which…”
cites § 46.102 2×cited by 7 cases
Where it cites § 46.102
“” 45 C.F.R. § 46.102 (d). The regulations define an IRB as “an institutional review board established in accord with and for the purposes expressed in this policy.”
11
GREENGeier v. Maryland State Bd. of Physicians, 116 A.3d 1026 (Md. Ct. Spec. App. 2015).
cites § 46.102 1×cited by 10 cases
Where it cites § 46.102
“” He argues that, because “institution” is defined in 45 C.F.R. § 46.102 (b) as a “public or private entity or agency,” ICI, a corporation, not Dr.”
Later courts cite it for
“uncovered evidence that directly demonstrated bad faith, malice, and irregularities (i.e., misconduct) committed by the board and its members and the administrative prosecutor against him in” · 1 citing court
12
GREENC.K. v. Shalala, 883 F. Supp. 991 (D.N.J. 1995).
cites § 46.102 1×cited by 8 cases
Where it cites § 46.102
“at 1210 (citing 45 C.F.R. § 46.102 (d)), rev’d on other grounds, 30 F.”
The case’s holding
A state welfare program that eliminates benefit increases for additional children does not violate constitutional procreative rights if it does not condition the receipt of benefits upon reproductive choices.
Later courts cite it for
“in no way conditions receipt of benefits upon plaintiffs' reproductive choices.” · 3 citing courts
13
GREENLifchez v. Hartigan, 735 F. Supp. 1361 (N.D. Ill. 1990).
cites § 46.102 1×cited by 7 cases
Where it cites § 46.102
“” 45 C.F.R. § 46.102 (e) (1989). The legislative history of § 6(7) is unenlightening as far as nailing down a particularized meaning of “experiment” to counter the vagueness that Dr.”
14
NEUTRALMatter of Mental Hygiene Legal Serv. v. Sullivan, 153 A.D.3d 114 (N.Y. App. Div. 3d Dep't 2017).
cites § 46.102 2×cited by 2 cases
Where it cites § 46.102
“The legislative history confirms this interpretation, revealing that the language was narrowly drafted so that individuals authorized to assist "in drawing up the treatment plan" could attend the planning meetings (Mem of Economic Development Board, Bill Jacket, L 1976, ch 332,…”
15
NO FLAGBryan Pesta v. Cleveland State Univ., No. 24-3947 (6th Cir. Nov. 4, 2025).
cites § 46.102 2×cited by 0 casesunpublished
Where it cites § 46.102
“64-1, PageID 3851–52 (citing 45 C.F.R. § 46.102 (e)(1)). Crucially, in Pesta’s view, the relevant regulations’ definition of “human subject[]” contemplates a researcher gathering data from the subject through direct intervention or interaction, 45 C.”
16
NO FLAGSherley v. Sebelius, No. 2009-1575 (D.D.C. Aug. 23, 2010).
cites § 46.102 2×cited by 0 cases
Summary
No passage or summary on file for this case yet.
17
NO FLAGPersson v. Boston Univ., No. 1:15-cv-14037, 2019 WL 917205 (D. Mass. Feb. 25, 2019).
cites § 46.102 1×cited by 0 casesunknown
Where it cites § 46.102
“See 45 C.F.R. §§ 46.102 , 46.109, 46.118. In December 2008, the plaintiff received a performance evaluation of her work as a research administrator.”
18
NO FLAGSherley v. Sebelius, No. 2009-1575 (D.D.C. July 27, 2011).
cites § 46.102 1×cited by 0 cases
Where it cites § 46.102
“(quoting 45 C.F.R. § 46.102 (d)). Rejecting defendants’ argument that “research” meant “a piece of research,” this Court found that the Dickey-Wicker Amendment’s prohibition “encompasses all ‘research in which’ an embryo is destroyed, not just the ‘piece of research’ in which…”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
197620002025

One bar per year. Tallest: 3 cases in 2011. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
D.D.C.4D.C. Cir.26th Cir.1Conn.1N.D. Ga.1N.D. Ill.1E.D. La.1D. Mass.1

The 8 courts with the most citing cases, of 14 courts in all.

By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com